Mayte Gil-Candel
8PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull
|Feb 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.Octavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria
|Apr 21, 2022
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results.Mayte Gil-Candel, Antonio Solana-Altabella, Esther Vicente-Escrig
|Jan 25, 2021
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival.Carles Iniesta Navalón, Maite Gil Candel, Ignacio Salar Valverde
|Nov 20, 2020
Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study.Rosa Gómez Espín, Isabel Nicolás De Prado, Mayte Gil Candel
|Jul 21, 2020
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients.Mayte Gil Candel, Juan José Gascón Cánovas, Rosa Gómez Espín
Pageof 2
Frequent Collaborators
5 joint publications
Carles Iniesta-Navalón
3 joint publications
Antonio Solana-Altabella
2 joint publications
Juan Eduardo Megías-Vericat
2 joint publications
José Luis Poveda-Andrés
1 joint publications
Octavio Ballesta-López
1 joint publications
María Centelles-Oria
1 joint publications
Hugo Ribes-Artero
1 joint publications
Pilar Nos-Mateu
1 joint publications
Maria Chovi-Trull
1 joint publications
Marina Lopez-Nogueroles
